Metraipolis › archive › dc_a5bdbe7357e4

Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer — Europe PMC PMID:41280919

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41280919
DOI
10.3389/fimmu.2025.1670841
License (as archived)
solo-consultazione
Archived
2026-11-08T18:16:35.107Z
SHA-256 of the archived text
13f882d623b1ef08c1099b8ae9274a8f1cb8b64ee2b371c4423b962b06af2cd2
Stable URL of this page
https://metraipolis.com/documento/dc_a5bdbe7357e4

How to cite

Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer — Europe PMC PMID:41280919 — Europe PMC (en), https://europepmc.org/article/MED/41280919 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5bdbe7357e4 (Metraipolis archive dc_a5bdbe7357e4, sha256 13f882d623b1ef08c1099b8ae9274a8f1cb8b64ee2b371c4423b962b06af2cd2)
BibTeX
@misc{dca5bdbe7357e4,
  title = {Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer — Europe PMC PMID:41280919},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280919},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5bdbe7357e4; sha256 13f882d623b1ef08c1099b8ae9274a8f1cb8b64ee2b371c4423b962b06af2cd2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280919. Agents can read the archived copy with the MCP tool read_document.